| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
FULC sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 8.85M | $118.00M | - | |
| 10% | 7.08M | $24.92M | - | |
| Other | 650.0K | - | - | |
| CFO | 170.0K | - | - | |
| Other | 170.0K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 17, 2026 | Tang Kevin85 | 10% Owner | Buy | 167,616 | $3.55 | $594,675.16 | +2.4% | +0.5% | - | |
| Jul 15, 2026 | Tang Kevin85 | 10% Owner | Buy | 249,946 | $3.57 | $891,067.48 | +3.8% | +3.4% | - | |
| Jun 26, 2026 | Ezekowitz Alan86 | Director | Sell | 18,000 | $3.65 | $65,613.60 | -62.2% | -0.4% | - | |
| Feb 2, 2026 | Gould Robert J85 | Director | Sell | 15,000 | $10.72 | $160,857.00 | -3.2% | -34.5% | - | |
| Jan 2, 2026 | Gould Robert J85 | Director | Sell | 15,000 | $11.87 | $178,089.00 | -3.1% | -26.4% | - | |
| Dec 15, 2025 | Oltmans Curtis Gale | Chief Legal Officer | Sell | 3,452 | $12.92 | $44,599.84 | -25.2% | -42.4% | - | |
| Dec 8, 2025 | Ra Capital Management, L.P.52 | 10% Owner | Sell | 4,175,139 | $13.98 | $58,377,021.32 | -40.8% | -39.0% | - | |
| Nov 19, 2025 | Gould Robert J85 | Director | Sell | 15,000 | $11.03 | $165,495.00 | -3.0% | -7.4% | - | |
| May 8, 2025 | Tourangeau Greg49 | Principal Accounting Officer | Sell | 498 | $5.06 | $2,519.88 | -3.4% | +28.3% | +29.6% | |
| May 7, 2024 | Tourangeau Greg49 | Principal Accounting Officer | Sell | 236 | $7.76 | $1,831.36 | -2.0% | +12.2% | -32.8% |